(S)-4-Benzyl-2-(6-cyclopropylpyridin-2-yl)-4,5-dihydrooxazole

Catalog No. :
ACQIUD214
CAS No. :
2828438-61-3
Molecular Formula :
C18H18N2O
Molecular Weight :
278.36

IUPAC Name:(S)-4-benzyl-2-(6-cyclopropylpyridin-2-yl)-4,5-dihydrooxazole

(S)-4-Benzyl-2-(6-cyclopropylpyridin-2-yl)-4,5-dihydrooxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$72.00Login to see priceIn stockInquiry
250mg95%$151.00Login to see priceIn stockInquiry
1g95%$472.00Login to see priceIn stockInquiry
5g95%$1887.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-4-Benzyl-2-(6-cyclopropylpyridin-2-yl)-4,5-dihydrooxazole
IUPAC Name(S)-4-benzyl-2-(6-cyclopropylpyridin-2-yl)-4,5-dihydrooxazole
MDL No.MFCD34705756
Molecular FormulaC18H18N2O
Molecular Weight278.36
SMILESC1(C2=NC(C3CC3)=CC=C2)=N[C@H](CO1)CC4=CC=CC=C4
InChI KeyVJKQWPKASQIGHC-HNNXBMFYSA-N
SynonymPyridine, 2-cyclopropyl-6-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-
CAS No.2828438-61-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACQIUD214 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9 In Stock
  4. Then
  5. ACQIUD214 route product structure diagram
    ACQIUD2142828438-61-3 In Stock
Inquiry

2. ACQIUD214 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9 In Stock
  4. Then
  5. ACQIUD214 route product structure diagram
    ACQIUD2142828438-61-3 In Stock
Inquiry

Comments (0)